• H.R.2529/S.1368, Restoring Access to Medication Act. Issues related to insuring access to over-the-counter drugs and Flexible Spending Accounts/Health Savings Accounts.
• S.3376, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; S.3187, Food and Drug Administration Safety and Innovation Act; issues related to insuring access to over-the-counter drugs.

Duration: April 1, 2011 to September 30, 2012

General Issues: Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Food Industry (Safety, Labeling, etc.)

Spending: about $300,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: House of Representatives, U.S. Senate